THRD
Third Harmonic Bio Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$242.79M
P/E Ratio
—
EPS
$-1.24
Beta
2.13
52W High
$5.53
52W Low
$3.47
50-Day MA
$5.40
200-Day MA
$6.51
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Third Harmonic Bio Inc.
Third Harmonic Bio Inc. is a pioneering biotechnology firm focused on creating groundbreaking therapies for severe immunology and inflammation-related disorders. Leveraging a proprietary genetic engineering platform, the company is advancing an innovative pipeline of drug candidates designed to meet critical unmet medical needs in this therapeutic area. With a strong dedication to scientific rigor and enhancing patient outcomes, Third Harmonic Bio is well-positioned to make a significant impact on the biopharmaceutical sector and improve the quality of care for patients confronting substantial health challenges.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-64.25M |
| Operating Margin | 0.00% |
| Return on Equity | -19.90% |
| Return on Assets | -14.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.06 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.09 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $45.13M |
| Float | $15.60M |
| % Insiders | 9.11% |
| % Institutions | 80.12% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank
51.6%
Volatility is currently contracting
Data last updated: 4/9/2026